Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Bicycle Therapeutics Plc ADR (BCYC)

Bicycle Therapeutics Plc ADR (BCYC)
12.11 x 14 17.50 x 2
Post-market by (Cboe BZX)
13.20 -0.36 (-2.65%) 01/22/25 [NASDAQ]
12.11 x 14 17.50 x 2
Post-market 13.20 unch (unch) 16:41 ET
Quote Overview for Wed, Jan 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
12.61
Day High
13.45
Open 13.37
Previous Close 13.56 13.56
Volume 287,832 287,832
Avg Vol 384,777 384,777
Stochastic %K 14.22% 14.22%
Weighted Alpha -40.56 -40.56
5-Day Change -1.61 (-10.87%) -1.61 (-10.87%)
52-Week Range 12.17 - 28.67 12.17 - 28.67
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 936,264
  • Shares Outstanding, K 69,046
  • Annual Sales, $ 26,980 K
  • Annual Income, $ -180,660 K
  • EBIT $ -196 M
  • EBITDA $ -190 M
  • 60-Month Beta 0.92
  • Price/Sales 18.94
  • Price/Cash Flow N/A
  • Price/Book 1.11

Options Overview Details

View History
  • Implied Volatility 47.10% ( -5.62%)
  • Historical Volatility 125.59%
  • IV Percentile 1%
  • IV Rank 3.78%
  • IV High 148.37% on 11/26/24
  • IV Low 43.12% on 06/03/24
  • Put/Call Vol Ratio 0.09
  • Today's Volume 35
  • Volume Avg (30-Day) 62
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 1,355
  • Open Int (30-Day) 1,473

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.85
  • Number of Estimates 7
  • High Estimate -0.68
  • Low Estimate -1.01
  • Prior Year -1.16
  • Growth Rate Est. (year over year) +26.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.61 +4.68%
on 01/22/25
Period Open: 14.68
15.47 -14.67%
on 01/07/25
-1.48 (-10.08%)
since 12/20/24
3-Month
12.17 +8.46%
on 12/13/24
Period Open: 26.21
26.57 -50.32%
on 10/23/24
-13.01 (-49.64%)
since 10/22/24
52-Week
12.17 +8.46%
on 12/13/24
Period Open: 17.78
28.67 -53.96%
on 10/16/24
-4.58 (-25.76%)
since 01/22/24

Most Recent Stories

More News
Why Shares of Bicycle Therapeutics Were Rising on Monday

The company said it is working with the FDA to structure a phase 2/3 trial for its bladder cancer therapy.

NVS : 98.17 (-1.56%)
BCYC : 13.20 (-2.65%)
Why Bicycle Therapeutics Stock Raced Ahead Today

The company's latest attempt at capital raising seems to be having enviable success.

GS : 632.73 (-0.32%)
JEF : 76.87 (-1.28%)
BCYC : 13.20 (-2.65%)
Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ® ) technology, today...

BCYC : 13.20 (-2.65%)
Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle® ) technology, today announced...

BCYC : 13.20 (-2.65%)
Bicycle Therapeutics to Present at the 2023 AACR Annual Meeting

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ® ) technology, today...

BCYC : 13.20 (-2.65%)
Bicycle Therapeutics Enhances Leadership Team with Key Appointments

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ® ) technology, today announced...

BCYC : 13.20 (-2.65%)
Bicycle Therapeutics Announces a Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ® ) technology, today announced...

BCYC : 13.20 (-2.65%)
Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ® ) technology, today announced...

BCYC : 13.20 (-2.65%)
Bicycle Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ® ) technology, today reported...

BCYC : 13.20 (-2.65%)
Bicycle Therapeutics Announces Phase I Dose Escalation Results from Ongoing Phase I/II Study of BT8009

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ® ) technology, today announced...

BCYC : 13.20 (-2.65%)

Business Summary

Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company. It is focused on developing medicines, referred to as Bicycles(R) for diseases which are underserved by existing therapeutics. Bicycle Therapeutics plc is based in Cambridge, United Kingdom.

See More

Key Turning Points

3rd Resistance Point 14.40
2nd Resistance Point 13.93
1st Resistance Point 13.56
Last Price 13.20
1st Support Level 12.72
2nd Support Level 12.25
3rd Support Level 11.88

See More

52-Week High 28.67
Fibonacci 61.8% 22.37
Fibonacci 50% 20.42
Fibonacci 38.2% 18.47
Last Price 13.20
52-Week Low 12.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar